The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

While the drugs certainly contribute to weight loss and health gains, they also cause a decline in muscle that some doctors ...

For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is expected at 16-24% growth. However, this forecast, 3% lower for revenue and ...

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in the first head-to-head study of the blockbuster medications. Clinical ...

A pronouncement from President Trump about the category drove their share prices down, although not to bargain-basement ...

They are the two drugs of the moment, the weight loss products promising a miraculous solution to obesity and—in data ...

President Donald Trump's executive order directs pharmaceutical companies to lower their prices to levels closer to those ...

President Donald Trump signed an executive order that claims to force Big Medicine to lower prescription drug prices paid by ...

For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is ...

One of the major concerns among aging men nowadays is the accumulation of excess belly fat. It’s not only unattractive and ...

Welcome to the Relmada Therapeutics first-quarter 2025 earnings call. (Operator Instructions) As a reminder, this conference is being recorded, and will be available for replay on the location website ...